NasdaqGM - Nasdaq Real Time Price USD
Avidity Biosciences, Inc. (RNA)
26.17
-0.09
(-0.34%)
At close: May 7 at 4:00:01 PM EDT
24.01
-2.16
(-8.25%)
Pre-Market: 4:00:43 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 497,380 | 19 |
| Sales | 400,197 | 26 |
| Net Shares Purchased (Sold) | 97,183 | 45 |
| Total Insider Shares Held | 6.2M | -- |
| % Net Shares Purchased (Sold) | 1.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MACLEAN MICHAEL F. Chief Financial Officer | Sale at price 31.06 per share. | Direct | 246,425 | Mar 20, 2025 |
| BOYCE SARAH Chief Executive Officer | Sale at price 31.06 per share. | Direct | 979,563 | Mar 20, 2025 |
| HUGHES STEVEN GEORGE Officer | Sale at price 31.06 per share. | Direct | 297,491 | Mar 20, 2025 |
| FLANAGAN WILLIAM MICHAEL Officer | Sale at price 31.06 per share. | Direct | 365,868 | Mar 20, 2025 |
| MCCARTHY TERESA Officer | Sale at price 31.06 per share. | Direct | 241,583 | Mar 20, 2025 |
| FLANAGAN WILLIAM MICHAEL Officer | Sale at price 30.13 per share. | Direct | 602,614 | Mar 11, 2025 |
| FLANAGAN WILLIAM MICHAEL Officer | Conversion of Exercise of derivative security at price 14.22 per share. | Direct | 284,400 | Mar 11, 2025 |
| LEVIN ARTHUR A. Director | Sale at price 28.60 per share. | Direct | 53,537 | Jan 21, 2025 |
| MACLEAN MICHAEL F. Chief Financial Officer | Sale at price 28.59 per share. | Direct | 93,985 | Jan 21, 2025 |
| BOYCE SARAH Chief Executive Officer | Sale at price 28.59 per share. | Direct | 297,291 | Jan 21, 2025 |
| HUGHES STEVEN GEORGE Officer | Sale at price 28.59 - 28.60 per share. | Direct | 112,856 | Jan 21, 2025 |
| FLANAGAN WILLIAM MICHAEL Officer | Sale at price 28.59 - 28.60 per share. | Direct | 162,192 | Jan 21, 2025 |
| MCCARTHY TERESA Officer | Sale at price 28.59 - 28.60 per share. | Direct | 84,612 | Jan 21, 2025 |
| MCCARTHY TERESA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| CALDERARO CHARLES III Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| MACLEAN MICHAEL F. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| MORIARTY JOHN B Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| BOYCE SARAH Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| MOSBROOKER ERIC B. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| HUGHES STEVEN GEORGE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| FLANAGAN WILLIAM MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| MACLEAN MICHAEL F. Chief Financial Officer | Sale at price 32.66 per share. | Direct | 364,192 | Dec 18, 2024 |
| BOYCE SARAH Chief Executive Officer | Sale at price 32.66 per share. | Direct | 1,040,384 | Dec 18, 2024 |
| FLANAGAN WILLIAM MICHAEL Officer | Sale at price 32.66 per share. | Direct | 416,154 | Dec 18, 2024 |
| MCCARTHY TERESA Officer | Sale at price 32.66 per share. | Direct | 364,192 | Dec 18, 2024 |
| MCCARTHY TERESA Officer | Sale at price 33.26 per share. | Direct | 831,605 | Dec 16, 2024 |
| MCCARTHY TERESA Officer | Conversion of Exercise of derivative security at price 14.22 per share. | Direct | 355,500 | Dec 16, 2024 |
| FLANAGAN WILLIAM MICHAEL Chief Technology Officer | Sale at price 35.77 per share. | Direct | 858,401 | Dec 11, 2024 |
| FLANAGAN WILLIAM MICHAEL Chief Technology Officer | Conversion of Exercise of derivative security at price 22.47 per share. | Direct | 539,280 | Dec 11, 2024 |
| LEVIN ARTHUR A. Director | Sale at price 42.12 per share. | Direct | 139,973 | Nov 19, 2024 |
| LEVIN ARTHUR A. Director | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 4,121 | Nov 19, 2024 |
| MCCARTHY TERESA Officer | Sale at price 41.14 per share. | Direct | 1,028,520 | Nov 18, 2024 |
| MCCARTHY TERESA Officer | Conversion of Exercise of derivative security at price 14.22 per share. | Direct | 355,500 | Nov 18, 2024 |
| MACLEAN MICHAEL F. Chief Financial Officer | Sale at price 45.33 - 46.22 per share. | Direct | 4,843,979 | Nov 6, 2024 |
| MACLEAN MICHAEL F. Chief Financial Officer | Conversion of Exercise of derivative security at price 6.57 - 8.82 per share. | Direct | 666,064 | Nov 6, 2024 |
| LEVIN ARTHUR A. Director | Sale at price 46.63 per share. | Direct | 233,168 | Oct 21, 2024 |
| LEVIN ARTHUR A. Director | Conversion of Exercise of derivative security at price 1.24 per share. | Direct | 6,200 | Oct 21, 2024 |
| MCCARTHY TERESA Officer | Sale at price 48.52 per share. | Direct | 1,213,010 | Oct 16, 2024 |
| MCCARTHY TERESA Officer | Conversion of Exercise of derivative security at price 14.22 per share. | Direct | 355,500 | Oct 16, 2024 |
| THOMPSON TAMAR Director | Sale at price 44.98 per share. | Direct | 1,349,259 | Oct 7, 2024 |
| THOMPSON TAMAR Director | Conversion of Exercise of derivative security at price 27.63 per share. | Direct | 828,900 | Oct 7, 2024 |
| FLANAGAN WILLIAM MICHAEL Chief Technology Officer | Sale at price 47.62 per share. | Direct | 2,976,112 | Oct 1, 2024 |
| FLANAGAN WILLIAM MICHAEL Chief Technology Officer | Conversion of Exercise of derivative security at price 26.75 per share. | Direct | 1,671,875 | Oct 1, 2024 |
| MACLEAN MICHAEL F. Chief Financial Officer | Sale at price 44.00 per share. | Direct | 506,440 | Sep 23, 2024 |
| BOYCE SARAH Chief Executive Officer | Sale at price 44.00 per share. | Direct | 1,446,723 | Sep 23, 2024 |
| FLANAGAN WILLIAM MICHAEL Officer | Sale at price 43.89 - 44.00 per share. | Direct | 1,098,733 | Sep 23, 2024 |
| MCCARTHY TERESA Officer | Sale at price 44.00 per share. | Direct | 578,737 | Sep 23, 2024 |
| LEVIN ARTHUR A. Director | Sale at price 45.73 per share. | Direct | 228,658 | Sep 19, 2024 |
| MCCARTHY TERESA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 19, 2024 |
| MACLEAN MICHAEL F. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 19, 2024 |
Related Tickers
ACLX Arcellx, Inc.
52.94
+0.27%
DYN Dyne Therapeutics, Inc.
9.40
-6.19%
PCVX Vaxcyte, Inc.
29.00
-0.82%
KRYS Krystal Biotech, Inc.
136.80
-1.91%
PTCT PTC Therapeutics, Inc.
40.76
+12.63%
CYTK Cytokinetics, Incorporated
33.04
-2.74%
DNLI Denali Therapeutics Inc.
14.32
+2.51%
APLS Apellis Pharmaceuticals, Inc.
17.99
-5.91%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
AKRO Akero Therapeutics, Inc.
42.79
+1.83%